PHB2

Chr 12

prohibitin 2

Also known as: BAP, BCAP37, Bap37, PNAS-141, REA, hBAP, p22

Enables obsolete amide binding activity; protein dimerization activity; and sphingolipid binding activity. Involved in several processes, including RIG-I signaling pathway; antiviral innate immune response; and regulation of DNA-templated transcription. Located in several cellular components, including cell surface; mitochondrial membrane; and nuclear matrix. Part of mitochondrial prohibitin complex. [provided by Alliance of Genome Resources, Jun 2026]

OMIMResearchGenerating clinical summary…
0
Active trials
84
Pubs (1 yr)
P/LP submissions
P/LP missense
0.66
LOEUF
DN
Mechanism· predicted

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.66LOEUF
pLI 0.004
Z-score 2.77
OE 0.36 (0.210.66)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
1.99Z-score
OE missense 0.58 (0.490.68)
102 obs / 176.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.36 (0.210.66)
00.351.4
Missense OE?0.58 (0.490.68)
00.61.4
Synonymous OE?0.85
01.21.6
LoF obs/exp: 8 / 22.0Missense obs/exp: 102 / 176.2Syn Z: 0.96

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

PHB2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →